PCF Group S.A. completed a private subscription for 3,343,037 Series F ordinary shares at an issue price of 40.20 PLN per share.
See it on page 1The total gross proceeds from the share issuance amounted to 134,390,087.40 PLN.
See it on page 2The subscription process concluded with full payment received by 9 June 2023, following a subscription period that ran from 29 May to 1 June 2023.
See it on page 2The entire offering was acquired by two investors, with no tranches or secondary allocations utilized.
See it on page 2Detailed costs associated with the issuance are currently pending and will be disclosed in a future report once all invoices are finalized.
See it on page 3The offering was conducted exclusively for qualified investors in the EEA, the UK, and specific U.S. institutional investors under Rule 144A, requiring no prospectus.
See it on page 5The report announces the completion of a private subscription offering for 3,343,037 ordinary Series F shares of PCF Group S.A., each with a nominal value of 0.02 PLN, issued at an emission price of 40.20 PLN per share. The subscription period ran from 29 May to 1 June 2023, with contracts finalized on 6 June and full payment received by 9 June. Two investors participated, acquiring the entire offering; no tranches or secondary allocations were involved. The total value of the issuance amounted to 134,390,087.40 PLN. Costs associated with the offering are pending finalization; a separate report will disclose detailed expense breakdowns and per‑share cost once all invoices are received. The document clarifies that the shares were offered exclusively within Poland, with no prospectus required under EU Prospectus Regulation, and that the offering is restricted to qualified investors in the European Economic Area, the United Kingdom, and certain U.S. institutional investors under Rule 144A. Legal notices emphasize that the report is informational only, not an offer or recommendation, and that distribution outside specified jurisdictions is prohibited. The report also contains forward‑looking statements subject to risks, uncertainties, and regulatory constraints, underscoring that investors should conduct independent due diligence before participating.